This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 93/10/3936    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Google Scholar Articles by Lamb, M. M. Articles by Norris, J. M. PubMed PubMed Citation Articles by Lamb, M. M. Articles by Norris, J. M. Related Collections Pediatric Endocrinology Autoimmunity Diabetes and Insulin

Dietary Glycemic Index, Development of Islet Autoimmunity, and Subsequent Progression to Type 1 Diabetes in Young Children

University of Colorado Denver (M.M.L., X.Y., A.E.B., M.R., J.M.N.), Denver, Colorado 80262; and Barbara Davis Center for Childhood Diabetes (K.B., M.R.H., G.S.E., M.R.), Aurora, Colorado 80045

Address all correspondence and requests for reprints to: Dr. Jill M. Norris, University of Colorado Denver, 4200 East 9th Avenue, Box B-119, Denver, Colorado 80262. E-mail: Jill.Norris{at}uchsc.edu.

Context: Dietary factors may trigger or exacerbate the autoimmune disease process.

Objective: Our objective was to examine dietary glycemic index (GI) and glycemic load (GL) for association with islet autoimmunity (IA) development, and progression from IA to type 1 diabetes.

Design: The Diabetes Autoimmunity Study in the Young follows children at increased genetic type 1 diabetes risk. Diet is collected prospectively via a parent-reported food frequency questionnaire.

Setting: This was an observational study of children in the Denver area.

Patients: A total of 1776 Diabetes Autoimmunity Study in the Young children younger than 11.5 yr was included in the study.

Interventions: There were no interventions.

Main Outcome Measures: IA, defined as the presence of autoantibodies to insulin, glutamic acid decarboxylase, or protein tyrosine phosphatase at two consecutive visits, or the presence of autoantibodies at one visit and diabetic on the next consecutive visit was determined. Type 1 diabetes was diagnosed by a physician. A total of 89 subjects developed IA, and 17 subsequently developed type 1 diabetes during follow-up. Our hypothesis was formulated after data collection.

Results: GI and GL were not associated with IA development. More rapid progression to type 1 diabetes in children with IA was associated with higher dietary GI (hazard ratio: 2.20; 95% confidence interval: 1.17–4.15) and marginally associated with GL (hazard ratio: 1.59; 95% confidence interval: 0.96–2.64) at the first IA-positive visit.

Conclusions: Higher dietary GI and GL are not associated with IA development, but higher GI is associated with more rapid progression to type 1 diabetes in children with IA, perhaps due to increased demand on the β-cell to release insulin. Further study is needed to confirm this finding and identify the underlying biological mechanism.